Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03881046
Recruitment Status : Enrolling by invitation
First Posted : March 19, 2019
Last Update Posted : March 19, 2019
Sponsor:
Information provided by (Responsible Party):
Hamide Sahin, Hacettepe University

Brief Summary:
The aim of our study was to compare the daily living activities with a performance-based protocol in lung cancer patients and healthy controls.

Condition or disease
Lung Cancer

Detailed Description:

Lung cancer is the abnormal proliferation of cells in the lung tissue and a mass in the lung. The primary symptoms of this health problem include cough, dyspnea, chest pain, hemoptysis and sputum. In addition to these symptoms, muscle strength, respiratory function and effort level are decreased.

Inadequate daily living activities in cancer patients are expressed.But studies evaluating the activities of daily living in patients with lung cancer are inadequate and patients are evaluated only using scales. For the measurement of functional status in daily living activities, these scales provide important information about the detection of symptoms and the progression of the disease. However, it is very difficult to determine the limitation of perceived difficulty in daily living activities with these scales. In addition, since these scales are a method of measurement, the objectivity is open to discussion. It is thought that a performance-based protocol will facilitate the detection of limitations and provide more objective findings. We think that the Londrina protocol fully reflects the activities of daily living and thus will give us an objective measurement.

This study will show us the problem and its cause in daily life activities in patients with lung cancer.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 44 participants
Observational Model: Case-Control
Time Perspective: Prospective
Target Follow-Up Duration: 1 Day
Official Title: Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer
Actual Study Start Date : September 1, 2018
Estimated Primary Completion Date : June 17, 2020
Estimated Study Completion Date : June 17, 2020

Resource links provided by the National Library of Medicine


Group/Cohort
lung cancer
healthy control group



Primary Outcome Measures :
  1. Activities Of Daily Living [ Time Frame: 1st day ]
    Daily Living Activities will be evaluated using the Londrina Protocol.The protocol consists of 5 stations. Stations are including organizing books on the table, 18 meters walking by carrying 10% of body weight symmetrically, arranging books by putting them on shelves, hanging the laundry in the laundry basket and walking 18 meters. İndividual will do these activities at his own pace and the time will be recorded at the end.


Secondary Outcome Measures :
  1. Life Quality [ Time Frame: 1st Day ]
    Quality of life will be measured using Core Quality of Life Questionnaire (EORTC QLQ-C30) The questionnaire consists of 30 questions and provides information on quality of life and symptoms.

  2. Peripheral Muscle Strength [ Time Frame: 1st Day ]
    Muscle strength will be evaluated by force measuring dynamometer device 3 times. M.Quadriceps Femoris, shoulder abduction, shoulder flexion, elbow flexion, elbow extension and hand grip strength of all cases will be measured.

  3. Dyspnoea [ Time Frame: 1st Day ]
    Dyspnoea will be evaluated using the Medical Research Council Dyspnoea Scale. The Medical Research Council Dyspnoea Scale has a score of 0-4. İn this scoring system 0 indicates that there is no dyspnoea, whereas 4 indicates that the dyspnoea is too high.

  4. Respiratory Functions [ Time Frame: 1st Day ]
    Respiratory functions will be measured by spirometric measurement. This measurement will give us FEV1 FVC FEV1 / FVC values.

  5. Exercise Capacity [ Time Frame: 1st Day ]
    6 Minute walk test will be used.In the test, the person will be asked to walk as fast as possible in a 30-meter corridor and the walking distance will be recorded in 6 minutes.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Individuals who are diagnosed with Lung Cancer at Hacettepe University and who reffered to the Cardiopulmonary Rehabilitation Unit for Physiotherapy also who are willing to participate in the study will be included in the study.
Criteria

Inclusion Criteria:

  • To have a diagnosis of lung cancer
  • Complete chemotherapy
  • Complete radiotherapy
  • Coopere,
  • Accepts participation in the study will be included in the study

Exclusion Criteria:

  • Neurological, cognitive or orthopedic diseases that affect the measurements
  • Acute infection
  • Individuals with other chronic diseases that may affect their walking will not be included in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03881046


Locations
Layout table for location information
Turkey
Hamide Sahin
Ankara, Turkey, 06105
Sponsors and Collaborators
Hacettepe University
Additional Information:

Layout table for additonal information
Responsible Party: Hamide Sahin, Multidimensional Evaluation Of Daily Living Activities And Quality Of Life In Lung Cancer Patients, Hacettepe University
ClinicalTrials.gov Identifier: NCT03881046    
Other Study ID Numbers: GO 18/737-08
First Posted: March 19, 2019    Key Record Dates
Last Update Posted: March 19, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases